ID rozhodnutia | ID návrhu | Stupeň | Typ rozhodnutia | Navrhovateľ | Zverejnené | Akcia |
---|---|---|---|---|---|---|
<< < 2 3 4 5 6 > >> | ||||||
R 8192 | 27816 | 1 | R_CND | Celltrion Healthcare Hungary Kft. | 15.2.2023 | Detaily |
R 8191 | 27637 | S | R_STOP | ALK-Abelló A/S | 15.2.2023 | Detaily |
R 8190 | 25309 | 1 | R_A1N | Bayer AG | 15.1.2023 | Detaily |
R 8189 | 25307 | 1 | R_A1N | Bayer AG | 15.1.2023 | Detaily |
R 8188 | 27306 | 2 | R_KON | Ministerstvo zdravotníctva | 15.1.2023 | Detaily |
R 8187 | 27463 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2023 | Detaily |
R 8186 | 27395 | 1 | R_KON | Ministerstvo zdravotníctva SR | 15.1.2023 | Detaily |
R 8185 | 27453 | 1 | R_KON | Ministerstvo zdravotníctva SR | 15.1.2023 | Detaily |
R 8184 | 27336 | S | R_STOP | Egis Pharmaceuticals Private Limited Company | 15.1.2023 | Detaily |
R 8183 | 27351 | S | R_STOP | Celltrion Healthcare Hungary Kft. | 15.1.2023 | Detaily |
R 8182 | 27344 | S | R_STOP | STADA Arzneimittel AG | 15.1.2023 | Detaily |
R 8181 | 27353 | S | R_STOP | Sandoz Pharmaceuticals d.d. | 15.1.2023 | Detaily |
R 8180 | 27354 | S | R_STOP | Pfizer Europe MA EEIG | 15.1.2023 | Detaily |
R 8179 | 27355 | S | R_STOP | Sandoz GmbH | 15.1.2023 | Detaily |
R 8178 | 27357 | S | R_STOP | Glenmark Pharmaceuticals s.r.o. | 15.1.2023 | Detaily |
R 8177 | 27358 | S | R_STOP | Accord Healthcare S.L.U | 15.1.2023 | Detaily |
R 8176 | 27374 | 1 | R_CND | BIAL-PORTELA & CA, S.A. | 15.1.2023 | Detaily |
R 8175 | 27206 | 1 | R_A1E | Egis Pharmaceuticals Private Limited Company | 15.1.2023 | Detaily |
R 8174 | 27205 | 1 | R_A1E | Egis Pharmaceuticals Private Limited Company | 15.1.2023 | Detaily |
R 8173 | 27252 | 1 | R_A1E | HEATON k.s. | 15.1.2023 | Detaily |
R 8172 | 27253 | 1 | R_A1E | HEATON k.s. | 15.1.2023 | Detaily |
R 8171 | 27255 | 1 | R_A1E | HEATON k.s. | 15.1.2023 | Detaily |
R 8170 | 27256 | 1 | R_A1E | HEATON k.s. | 15.1.2023 | Detaily |
R 8169 | 27126 | 1 | R_A1E | Zentiva k.s. | 15.1.2023 | Detaily |
R 8168 | 27127 | 1 | R_A1E | Zentiva k.s. | 15.1.2023 | Detaily |